FR2157865A1 - - Google Patents

Info

Publication number
FR2157865A1
FR2157865A1 FR7236560A FR7236560A FR2157865A1 FR 2157865 A1 FR2157865 A1 FR 2157865A1 FR 7236560 A FR7236560 A FR 7236560A FR 7236560 A FR7236560 A FR 7236560A FR 2157865 A1 FR2157865 A1 FR 2157865A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7236560A
Other languages
French (fr)
Other versions
FR2157865B1 (sv
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2157865A1 publication Critical patent/FR2157865A1/fr
Application granted granted Critical
Publication of FR2157865B1 publication Critical patent/FR2157865B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7236560A 1971-10-29 1972-10-16 Expired FR2157865B1 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (2)

Publication Number Publication Date
FR2157865A1 true FR2157865A1 (sv) 1973-06-08
FR2157865B1 FR2157865B1 (sv) 1975-10-31

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7236560A Expired FR2157865B1 (sv) 1971-10-29 1972-10-16

Country Status (25)

Country Link
JP (2) JPS5337870B2 (sv)
AR (2) AR198798A1 (sv)
AT (2) AT320656B (sv)
AU (1) AU467600B2 (sv)
BE (1) BE790125A (sv)
CA (1) CA980778A (sv)
CH (2) CH549579A (sv)
DE (3) DE2264374C3 (sv)
DK (1) DK131465B (sv)
EG (1) EG11013A (sv)
ES (2) ES407730A1 (sv)
FI (1) FI55503C (sv)
FR (1) FR2157865B1 (sv)
GB (2) GB1377308A (sv)
IE (1) IE37043B1 (sv)
IL (2) IL40458A (sv)
LU (1) LU66304A1 (sv)
NL (1) NL166470C (sv)
NO (1) NO136574C (sv)
PH (2) PH10129A (sv)
PL (2) PL84634B1 (sv)
SE (2) SE393376B (sv)
SU (2) SU498908A3 (sv)
YU (2) YU35125B (sv)
ZA (1) ZA727362B (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (sv) * 1979-04-17 1980-11-01
JPS5752409Y2 (sv) * 1979-11-05 1982-11-15
DE3222914A1 (de) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPH0655686B2 (ja) * 1988-08-30 1994-07-27 宇部興産株式会社 ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法
US7776870B2 (en) 2005-08-22 2010-08-17 Melior Pharmaceuticals I, Inc. Methods for modulating Lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US10786503B2 (en) 2017-04-10 2020-09-29 Melior Pharmaceuticals I, Inc. Treatment of adipocytes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
SE393376B (sv) 1977-05-09
DK131465C (sv) 1975-12-08
DE2248741B2 (de) 1974-11-14
AT321308B (de) 1975-03-25
NO136574B (sv) 1977-06-20
DE2248741A1 (de) 1973-05-03
ES407730A1 (es) 1976-01-16
PL89852B1 (sv) 1976-12-31
FR2157865B1 (sv) 1975-10-31
JPS4852780A (sv) 1973-07-24
PL84634B1 (sv) 1976-04-30
AT320656B (de) 1975-02-25
YU99179A (en) 1981-08-31
SU505362A3 (ru) 1976-02-28
SE397090B (sv) 1977-10-17
YU36295B (en) 1982-06-18
DE2264657A1 (de) 1974-06-20
NO136574C (no) 1977-09-28
DK131465B (da) 1975-07-21
PH11594A (en) 1978-03-31
YU255172A (en) 1980-03-15
AR198798A1 (es) 1974-07-24
ZA727362B (en) 1973-11-28
FI55503C (fi) 1979-08-10
AR196263A1 (es) 1973-12-10
EG11013A (en) 1976-11-30
DE2264374A1 (de) 1973-05-24
LU66304A1 (sv) 1973-05-03
IE37043B1 (en) 1977-04-27
ES436624A1 (es) 1977-02-01
SU498908A3 (ru) 1976-01-05
AU4722872A (en) 1974-04-04
DE2264657C2 (de) 1982-09-16
BE790125A (fr) 1973-04-16
IL48790A (en) 1976-05-31
NL7213959A (sv) 1973-05-02
PH10129A (en) 1976-09-02
JPS5337870B2 (sv) 1978-10-12
GB1377308A (en) 1974-12-11
JPS5422995B2 (sv) 1979-08-10
DE2264374B2 (de) 1980-08-07
DE2248741C3 (de) 1975-06-26
FI55503B (fi) 1979-04-30
AU467600B2 (en) 1975-12-04
IE37043L (en) 1973-04-29
JPS53116386A (en) 1978-10-11
CA980778A (en) 1975-12-30
IL40458A (en) 1976-05-31
CH555832A (fr) 1974-11-15
GB1377720A (en) 1974-12-18
YU35125B (en) 1980-09-25
SE7505279L (sv) 1975-05-06
CH549579A (fr) 1974-05-31
DE2264374C3 (de) 1981-07-23
IL48790A0 (en) 1976-03-31
NL166470B (nl) 1981-03-16
IL40458A0 (en) 1972-11-28
NL166470C (nl) 1981-08-17

Similar Documents

Publication Publication Date Title
ATA136472A (sv)
AU2658571A (sv)
AU2691671A (sv)
AU2485671A (sv)
AU3005371A (sv)
AU2952271A (sv)
AU2941471A (sv)
AU2894671A (sv)
AU2742671A (sv)
AU2684071A (sv)
AU2564071A (sv)
AU2473671A (sv)
AU2907471A (sv)
AU3038671A (sv)
AU2486471A (sv)
AU3025871A (sv)
AU2503871A (sv)
AU2456871A (sv)
AU2577671A (sv)
AU2588771A (sv)
AU2654071A (sv)
AU2455871A (sv)
AU2669471A (sv)
AU2415871A (sv)
AU2684171A (sv)

Legal Events

Date Code Title Description
ST Notification of lapse